LOCOREGIONALLY RECURRENT HORMONE-RECEPTOR POSITIVE BREAST CANCER
Clinical trials for LOCOREGIONALLY RECURRENT HORMONE-RECEPTOR POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONALLY RECURRENT HORMONE-RECEPTOR POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCOREGIONALLY RECURRENT HORMONE-RECEPTOR POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Find and Treat' approach tested for tough breast cancers
Disease control Recruiting nowThis early-stage study is testing a two-part approach for advanced breast cancer that has returned or spread. First, a new radioactive tracer (68Ga-R11228) is used in a PET scan to find cancer spots in the body. If the scan shows the cancer takes up the tracer, patients may then …
Matched conditions: LOCOREGIONALLY RECURRENT HORMONE-RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New scan aims to sharpen the picture of stubborn breast cancer
Diagnosis Recruiting nowThis early-stage study is testing a new radioactive imaging tracer called 68Ga-R10602 to see if it can better locate tumors in people with advanced, hormone-positive breast cancer. The study will enroll about 36 adults whose cancer has progressed despite prior treatments. The mai…
Matched conditions: LOCOREGIONALLY RECURRENT HORMONE-RECEPTOR POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC